| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.7860/JCDR/2015/9375.5391 |
| P8608 | Fatcat ID | release_o5hjrraqmbclbfirgrju4cv5u4 |
| P932 | PMC publication ID | 4347165 |
| P698 | PubMed publication ID | 25738074 |
| P2093 | author name string | Mohamed Farag | |
| P2860 | cites work | Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells | Q22255391 |
| Genes that mediate breast cancer metastasis to the brain | Q24644008 | ||
| Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer | Q47261967 | ||
| Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study. | Q53154903 | ||
| Drug use and acute leukemia | Q79898882 | ||
| Is aspirin useful in primary prevention? | Q27001149 | ||
| Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study | Q28167302 | ||
| Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia | Q28187147 | ||
| Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States) | Q28194947 | ||
| Low-dose aspirin affects the clinicopathological features of gastric cancer | Q28195916 | ||
| Regular analgesic use and risk of multiple myeloma | Q28200451 | ||
| Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival | Q28277824 | ||
| Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials | Q33767211 | ||
| Aspirin use and risk for lung cancer: a meta-analysis. | Q33840490 | ||
| Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study | Q33994275 | ||
| Aspirin and serum estrogens in postmenopausal women: a randomized controlled clinical trial | Q34135505 | ||
| Aspirin and cancer risk: a quantitative review to 2011. | Q34269637 | ||
| Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies | Q34603649 | ||
| Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis | Q34923812 | ||
| Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies | Q35136401 | ||
| Platelets and cancer metastasis: a causal relationship? | Q35477800 | ||
| Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial | Q35627411 | ||
| Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort | Q36478226 | ||
| Clinical evidence for the use of aspirin in the treatment of cancer | Q36755018 | ||
| Primary extraosseous Ewing sarcoma of the lung in children | Q36791086 | ||
| Prostaglandin E2 EP receptors as therapeutic targets in breast cancer | Q36806255 | ||
| Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells | Q36927955 | ||
| Aspirin use and risk of colorectal cancer according to BRAF mutation status | Q37094281 | ||
| Regular aspirin use and breast cancer risk in US Black women | Q37324216 | ||
| Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). | Q37366699 | ||
| Aspirin, salicylates, and cancer. | Q37425820 | ||
| Aspirin use and the risk of gastric cancer: a meta-analysis | Q37578339 | ||
| Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis | Q38252696 | ||
| Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells. | Q39181034 | ||
| Aspirin use and breast cancer risk: a meta-analysis | Q39710075 | ||
| Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California | Q41685994 | ||
| Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. | Q42540591 | ||
| Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality. | Q44131871 | ||
| The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. | Q44658657 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| P304 | page(s) | XE01-XE03 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Journal of clinical and diagnostic research JCDR | Q26842849 |
| P1476 | title | Can Aspirin and Cancer Prevention be Ageless Companions? | |
| P478 | volume | 9 |
| Q37687351 | A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment | cites work | P2860 |
Search more.